Joel Kaye
Overview
Explore the profile of Joel Kaye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ferrarotto R, Mishra V, Herz E, Yaacov A, Solomon O, Rauch R, et al.
Cell Death Dis
. 2022 Aug;
13(8):678.
PMID: 35931701
Adenoid cystic carcinoma (ACC) is an aggressive salivary gland malignancy with limited treatment options for recurrent or metastatic disease. Due to chemotherapy resistance and lack of targeted therapeutic approaches, current...
12.
Kaye J, Mondal A, Foty R, Jia D, Langenfeld J
Mol Cell Biochem
. 2022 Feb;
477(5):1583-1595.
PMID: 35192123
Glioblastomas (GBMs) are aggressive brain tumors that are resistant to chemotherapy and radiation. Bone morphogenetic protein (BMP) ligand BMP4 is being examined as a potential therapeutic for GBMs because it...
13.
Zeller S, Kaye J, Jumah F, Mantri S, Mir J, Raju B, et al.
J Neurosurg Pediatr
. 2021 Jul;
28(3):360-367.
PMID: 34214984
Objective: Laser interstitial thermal therapy (LITT) provides a minimally invasive alternative to open brain surgery, making it a powerful neurosurgical tool especially in pediatric patients. This systematic review aimed to...
14.
Rothhammer V, Kenison J, Li Z, Tjon E, Takenaka M, Chao C, et al.
Neurol Neuroimmunol Neuroinflamm
. 2021 Jan;
8(2).
PMID: 33408169
Objective: MS is an autoimmune demyelinating disease of the CNS, which causes neurologic deficits in young adults and leads to progressive disability. The aryl hydrocarbon receptor (AHR), a ligand-activated transcription...
15.
Kaye J, Daggubati L, Zeller S, McInerney J
Stereotact Funct Neurosurg
. 2020 Aug;
98(5):324-330.
PMID: 32810861
Background: Glossopharyngeal neuralgia (GPN) is a rare facial pain syndrome with debilitating symptoms. For medication-resistant GPN, stereotactic radiosurgery (SRS) is an emerging treatment option with a promising role; however, recurrence...
16.
Kaye J, Patel N, Danish S
Clin Exp Metastasis
. 2020 May;
37(3):435-444.
PMID: 32377943
Brain metastasis (BM) affects up to one-third of adults with cancer and carries a historically bleak prognosis. Despite advances in stereotactic radiosurgery (SRS), rates of in-field recurrence (IFR) after SRS...
17.
Kopanitsa M, Lehtimaki K, Forsman M, Suhonen A, Koponen J, Piiponniemi T, et al.
Genes Brain Behav
. 2020 May;
20(1):e12663.
PMID: 32372528
Cognitive problems frequently accompany neurological manifestations of multiple sclerosis (MS). However, during screening of preclinical candidates, assessments of behaviour in mouse models of MS typically focus on locomotor activity. In...
18.
Kaye J, Zeller S, Patel N, Herschman Y, Jumah F, Nanda A
World Neurosurg
. 2020 Feb;
137:78-83.
PMID: 32028002
Background: Brainstem cavernous malformations (CMs) represent dangerous clinical entities associated with high rates of rebleeding and morbidity compared with those in other locations. Particularly rare are those located within the...
19.
Nedelcu J, Reinbach C, Riedler P, Brendel M, Rominger A, Kaye J, et al.
Neurobiol Dis
. 2019 Nov;
134:104675.
PMID: 31731041
Accumulating evidence suggests that a degenerative processes within the brain can trigger the formation of new, focal inflammatory lesions in Multiple Sclerosis (MS). Here, we used a novel pre-clinical MS...
20.
Nyamoya S, Steinle J, Chrzanowski U, Kaye J, Schmitz C, Beyer C, et al.
Cells
. 2019 Nov;
8(11).
PMID: 31683658
Inflammatory demyelination, which is a characteristic of multiple sclerosis lesions, leads to acute functional deficits and, in the long term, to progressive axonal degeneration. While remyelination is believed to protect...